CD40 and influenza: The immunogenicity observed in the hu-mice model are consistent with those of our previous CD40-targeted influenza and HIV vaccine studies21,22,26,27 and demonstrate that αCD40.RBD could be a potent prime or boost vaccine for eliciting RBD-specific T- and B-cell responses19.